- Stocks
- Pharma & Healthcare
- Sharma East Ind
Sharma East Ind share price
NSE: SHARMEHPharma & HealthcareMedical Care Facilities
Sharma East Ind at a glance
With a market capitalisation of ₹33 Cr, it ranks 3323rd by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Medical Care Facilities.
Its return on equity was 10.0% in FY25.
Key numbers
- Market cap
- ₹33 CrRank 3323 on NSE
- Price to book
- 2.48×FY25
- ROE
- 10.0%FY25
- ROCE
- 15.4%FY25
- Debt to equity
- 0.18FY25
- Net profit margin
- 4.2%FY25
- Book value / share
- ₹30.01FY25
Returns to 22 Oct 2026
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | — | — | — | — | — |
Sharma East Ind financials
| Item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Revenue | ₹16 Cr | ₹8 Cr | ₹17 Cr | ₹21 Cr | ₹19 Cr | ₹30 Cr |
| Operating profit | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
| Net profit | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
| EPS (₹) | ₹1.18 | ₹1.94 | ₹2.07 | ₹2.96 | ₹2.02 | ₹3.79 |
| Cash from operations | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr | −₹1 Cr | ₹7 Cr |
| Total debt | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr |
| Shareholders' equity | ₹8 Cr | ₹9 Cr | ₹10 Cr | ₹11 Cr | ₹11 Cr | ₹12 Cr |
Sharma East Ind vs peers
The listed Pharma & Healthcare companies nearest to Sharma East Ind by market capitalisation.
Ask anything about Sharma East Ind
Pivot answers on the live chart with evidence you can check, and tests strategies against SHARMEH's own history. Try: “Why has SHARMEH moved over the last three months?” · “Backtest a 50-day moving-average crossover on SHARMEH over five years” · “Compare SHARMEH with JFLLIFE on margins and valuation”
Frequently asked questions about Sharma East Ind
What is the market cap of Sharma East Ind?
Sharma East Ind's market capitalisation is ₹33 Cr (₹33 Cr) at the 22 Oct 2026 close, ranking 3323rd among the NSE companies Pivot tracks.
What is the ROE and ROCE of Sharma East Ind?
Return on equity was 10.0% in FY25 and return on capital employed was 15.4% in FY25 (standalone figures).
Is Sharma East Ind a debt-free company?
No. Sharma East Ind's debt-to-equity ratio was 0.18 in FY25, with total debt of ₹1 Cr.
Who are Sharma East Ind's competitors?
The listed Pharma & Healthcare companies closest to Sharma East Ind by market cap are JFL Life Scienc, Chandra Bhagat, Deccan Health C, Medi-Caps, KK Shah Hospita and Panjon.
Is Sharma East Ind a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out Sharma East Ind's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on SHARMEH against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 22 Oct 2026 (returns and ratios at the 22 Oct 2026 close). Fundamentals: company filings via Moneycontrol, consolidated where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all Pharma & Healthcare stocks · companies starting with S · all NSE stocks · this page as text